ACACA and breast cancer: In breast cancer, miR-195, by targeting the 3′-UTR of ACC1, was demonstrated to inhibit cell proliferation, migration, and invasion, indicating that targeting ACC1 may be also an interesting strategy in breast cancer treatment [46].